Morningstar Investor users sign in here.

Stocks

InvoCare takeover bid ‘too cheap’

TPG Global’s takeover bid for ASX funeral provider InvoCare falls short of the company’s value, says Morningstar. 


A takeover bid for Australia’s leading death care provider would amount to a ‘steal’ if it went through at the current price offer, according to one Morningstar analyst.


TPG Global, a private equity company which specialises in alternative assets, put through a non-binding indicative offer for ASX-listed funeral and crematoria operator InvoCare (IVC) on Tuesday.

The $12.65-per-share offer sent shares in the company soaring more than 30% to around $12 apiece, where they have held steady during trading on Wednesday.

TPG acquired a 17.8% stake in InvoCare in a late raid on Monday, ahead of the formal takeover offer.

Morningstar analyst Angus Hewitt says the $1.81 billion bid comes in “too cheap”, pointing toward the opportunistic timing.

“We think TPG is looking to capitalise on share price weakness following relatively disappointing 2022 results.”

Despite the recent price surge, InvoCare shares remain undervalued compared to Morningstar's fair value estimate of $14.50 per share.

In recent months, InvoCare has continually been held up by Morningstar analysts as a potential buying opportunity, given the company’s wide-moat status and discounted share price relative to its fair value estimate.

The company’s recent trading history has been hampered by a downturn in deaths during the COVID-19 pandemic, but despite the short-term impact, Hewitt says the long-term outlook for the company remains strong.

“We expect InvoCare to remain the dominant force in Australian funerals and benefit from the industry dynamics of Australia’s growing and ageing population,” Hewitt adds.

Hewitt says TPG may have been attracted to the company’s “strong competitive position and dominant market share”.

Before TPG’s offer can be acceptedthe proposal will need InvoCare board support and the relevant investment committee and regulatory approvals, including from Australia’s Foreign Investment Board.

An assessment by the InvoCare board is underway.



© 2023 Morningstar, Inc. All rights reserved. Neither Morningstar, its affiliates, nor the content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. This report has been prepared for clients of Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or New Zealand wholesale clients of Morningstar Research Ltd, subsidiaries of Morningstar, Inc. Any general advice has been provided without reference to your financial objectives, situation or needs. For more information refer to our Financial Services Guide at www.morningstar.com.au/s/fsg.pdf. You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Our publications, ratings and products should be viewed as an additional investment resource, not as your sole source of information. Morningstar’s full research reports are the source of any Morningstar Ratings and are available from Morningstar or your adviser. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a financial adviser. Some material is copyright and published under licence from ASX Operations Pty Ltd ACN 004 523 782.

More from Morningstar

7 charts on the AI stock boom one year after ChatGPT’s launch
Stocks

7 charts on the AI stock boom one year after ChatGPT’s launch

These stocks and the key trends behind them are critical for understanding the AI investment landscape.
Why Berkshire Hathaway’s success will continue after Charlie Munger ... and Warren Buffett
Stocks

Why Berkshire Hathaway’s success will continue after Charlie Munger ... and Warren Buffett

Munger’s passing is a spiritual loss for the company.
Morningstar initiates coverage on 3 new shares
Stocks

Morningstar initiates coverage on 3 new shares

There are 2 undervalued names as part of our new coverage. 
3 shares for income investors
Stocks

3 shares for income investors

A dividend screen is a jumping off point for further research.
What we think of Morningstar subscribers' most traded share
Stocks

What we think of Morningstar subscribers' most traded share

This stock was the second largest ‘buy’ for 2023 and was also the second largest ‘sell’ for Morningstar subscribers.
How to build an income portfolio
Stocks

How to build an income portfolio

Investors love dividends but creating an income stream involves more than just picking the highest yielding shares.